Antinucleosome antibodies in patients with juvenile systemic lupus erythematosus

Lupus

Volumn 15, Issue 8, 2006, Pages 496-500

  Campos, Lucia M A ^a,c   Kiss, M H B ^a   Scheinberg, M A ^b   Mangueira, C L P ^a   Silva, C A ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c NONE   (Brazil)

Author keywords

Antinucleosome antibodies; Auto antibodies; Children; Disease activity; Systemic lupus erythematosus

Indexed keywords

NUCLEOSOME ANTIBODY;

ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ACTIVITY; ERYTHEMA; FEMALE; HEMOLYTIC ANEMIA; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ANTIBODIES, ANTINUCLEAR; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NUCLEOSOMES; STATISTICS; STATISTICS AS TOPIC;

EID: 33747872906     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2317oa     Document Type: Article

References (36)

1. Lehman TJA. Systemic lupus erythematosus in childhood and adolescence. In: Wallace DJ, Hahn BH eds. Dubois' Lupus Erythematosus, fifth edition. Williams and Williams, 1997: 851-870.
2. Van Bruggen MC, Kramers C, Walgreen B et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant 1997; 12: 57-66.
3. Amoura Z, Koutouzov S, Piette JC. The role of nucleosomes in lupus. Curr Opin Rheumatol 2000; 12: 369-373.
4. Bruns A, Blass S, Hausdorf G, Burmester GR, Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum 2000; 43: 2307-2315.
5. Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH. Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration. Arthritis Rheum 2001; 44: 1320-1330.
6. Dieker JWC, van der Vlag J, Berden JHM. Triggers for anti-chromatin autoantibody production in SLE. Lupus 2002; 11: 856-864.
7. Berden JHM, Grootscholten C, Dieker JWC, van der Vlag J. Lupus nephritis: a nucleosome waste disposal defect? J Nephrol 2002; 15: S1-10.
8. Kewalramani R, Singh AK. Immunopathogenesis of lupus and lupus nephritis: recent insights. Curr Opin Nephrol Hypertens 2002; 11: 273-277.
9. Koutouzov S, Jeronimo AL, Campos H, Amoura Z. Nucleosomes in the pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am 2004; 30: 529-558.
10. Goetz J. Nucleosome-specific antibodies in systemic lupus erythematosus. Pathol Biol 2002; 50: 581-583.
11. Schett G, Smole J, Zimmermann C et al. The autoimmune response to chromatin antigens in systemic lupus erythematosus: autoantibodies against histone H1 are a highly specific marker for SLE associated with increased disease activity. Lupus 2002; 11: 704-715.
12. Lepers S, Hachulla E, Leleux E, Hatron PY, Prin L, Dubucquoi S. Relevance of anti-nucleosome antibodies detected by enzyme-based immunoassays in lupus diagnosis. Comparative analysis of four commercial tests. Pathol Biol 2002; 50: 584-590.
13. Min DJ, Kim SJ, Park SH et al. Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheumatol 2002; 20: 13-18.
14. Cairns AP, Mcmillan SA, Crockard AD et al Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus. Ann Rheum Dis 2003; 62: 272-273.
15. Ghirardello A, Doria A, Zampieri S et al. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmun 2004; 22: 235-240.
16. Simon JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sanchez-Guerrero J. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology (Oxford) 2004; 43: 220-224.
17. Massa M, De Benedetti F, Pignatti P et al. Anti-double stranded DNA, anti-histone, and anti-nucleosome IgG reactivities in children with systemic lupus erythematosus. Clin Exp Rheumatol 1994; 12: 219-225.
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthrits Rheum 1997; 40: 1725.
19. Gladman DD, Ginzier E, Goldsmith CH et al. The development and inicial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
20. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
21. Hmida Y, Schmit P, Gilson G, Humbel RL. Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al. Arthritis Rheum 2002; 46: 280-228.
22. Amoura Z, Koutouzov S, Chabre H et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 2000; 43: 76-84.
23. Fisher CL, Eisenberg RA, Cohen PL. Quantitation and IgG subclass distribution of antichromatin autoantibodies in SLE mice. Clin Immunol Immunopathol 1988; 46: 205-213.
24. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 1993; 177: 1367-1381.
25. Amoura Z, Chabre H, Koutouzov S et al. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 1994; 37: 1684-1688.
26. Burlingame RW, Boey ML, Starkebaum G, Rubin RL. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994; 94: 184-192.
27. Chabre H, Amoura Z, Piette JC, Godeau P, Bach JF, Koutouzov S. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 1995; 38: 1485-1491.
28. Simon JA, Rojas-Serrano J, Cabiedes J, Alcocer-Varela J. Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome. Lupus 2004; 13: 177-181.
29. Cervera R, Vinas O, Ramos-Casals M et al. Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 2003; 62: 431-443.
30. Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology (Oxford) 2001; 40: 1405-1412.
31. Cortés-Hernández J, Ordi-Ros J, Labrador et al. Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med 2004; 116: 165-173.
32. Waters ST, McDuffie M, Bagavanth et al. Breaking tolerance to double stranded DNA, nucleosome, and on nuclear antigens not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004; 199: 255-264.
33. Benucci M, Gobbi FL, Del Rosso A, Cesaretti S, Niccoli L, Cantini F. Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol 2003; 32: 42-45.
34. Kaliyaperumal A, Michaels MA, Datta SK. Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus. J Immunol 2002; 168: 2530-2537.
35. Ghillani-Dalbin P, Amoura Z, Cacoub P et al. Testing for anti-nucleosome antibodies in daily practice: a monocentric evaluation in 1696 patients. Lupus 2003; 12: 833-837.
36. Horak P, Scudla V, Hermanovo Z et al. Clinical utility of selected disease activity markers in patients with systemic lupus erythematosus. Clin Rheumatol 2001; 20: 337-344.